277 related articles for article (PubMed ID: 20842541)
1. Physicochemical characterization of berberine chloride: a perspective in the development of a solution dosage form for oral delivery.
Battu SK; Repka MA; Maddineni S; Chittiboyina AG; Avery MA; Majumdar S
AAPS PharmSciTech; 2010 Sep; 11(3):1466-75. PubMed ID: 20842541
[TBL] [Abstract][Full Text] [Related]
2. Influence of hydroxypropyl-beta-cyclodextrin complexation on piroxicam release from buccoadhesive tablets.
Jug M; Bećirević-Laćan M
Eur J Pharm Sci; 2004 Feb; 21(2-3):251-60. PubMed ID: 14757497
[TBL] [Abstract][Full Text] [Related]
3. Dihydroartemisinin-cyclodextrin complexation: solubility and stability.
Ansari MT; Iqbal I; Sunderland VB
Arch Pharm Res; 2009 Jan; 32(1):155-65. PubMed ID: 19183889
[TBL] [Abstract][Full Text] [Related]
4. Influence of levodropropizine and hydroxypropyl-β-cyclodextrin association on the physicochemical characteristics of levodropropizine loaded in hydroxypropyl-β-cyclodextrin microcontainers: Formulation and in vitro characterization.
Yousaf AM; Qadeer A; Raza SA; Chohan TA; Shahzad Y; Din FU; Khan IU; Hussain T; Alvi MN; Mahmood T
Polim Med; 2019; 49(1):35-43. PubMed ID: 31769938
[TBL] [Abstract][Full Text] [Related]
5. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
Badr-Eldin SM; Elkheshen SA; Ghorab MM
Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
[TBL] [Abstract][Full Text] [Related]
6. Physicochemical characterization of efavirenz-cyclodextrin inclusion complexes.
Sathigari S; Chadha G; Lee YH; Wright N; Parsons DL; Rangari VK; Fasina O; Babu RJ
AAPS PharmSciTech; 2009; 10(1):81-7. PubMed ID: 19148759
[TBL] [Abstract][Full Text] [Related]
7. Improved Aqueous Solubility and Antihypercholesterolemic Activity of Ezetimibe on Formulating with Hydroxypropyl-β-Cyclodextrin and Hydrophilic Auxiliary Substances.
Srivalli KM; Mishra B
AAPS PharmSciTech; 2016 Apr; 17(2):272-83. PubMed ID: 26077622
[TBL] [Abstract][Full Text] [Related]
8. Binary inclusion complexes of diflunisal with β-cyclodextrin and hydroxypropyl-β-cyclodextrin: Preparation and characterization.
Bashir M; Syed HK; Asghar S; Irfan M; Aslam N; Iqbal MS; Khan IU; Shah PA; Khan NR; Ahmad J; Saleem M; Asif M
Pak J Pharm Sci; 2020 Sep; 33(5(Supplementary)):2307-2315. PubMed ID: 33832905
[TBL] [Abstract][Full Text] [Related]
9. Diloxanide furoate binary complexes with β-, methyl-β-, and hydroxypropyl-β-cyclodextrins: inclusion mode, characterization in solution and in solid state and in vitro dissolution studies.
Aloisio C; Longhi M
Pharm Dev Technol; 2018 Sep; 23(7):723-731. PubMed ID: 28758845
[TBL] [Abstract][Full Text] [Related]
10. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
[TBL] [Abstract][Full Text] [Related]
11. pH-dependent complexation of hydroxypropyl-beta-cyclodextrin with chlorin e6: effect on solubility and aggregation in relation to photodynamic efficacy.
Paul S; Heng PW; Chan LW
J Pharm Pharmacol; 2016 Apr; 68(4):439-49. PubMed ID: 26946047
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of oral bioavailability of cilostazol by forming its inclusion complexes.
Patel SG; Rajput SJ
AAPS PharmSciTech; 2009; 10(2):660-9. PubMed ID: 19459053
[TBL] [Abstract][Full Text] [Related]
13. Effect of hydroxypropyl beta-cyclodextrin on drug solubility in water-propylene glycol mixtures.
Chang RK; Shojaei AH
Drug Dev Ind Pharm; 2004 Mar; 30(3):297-302. PubMed ID: 15109029
[TBL] [Abstract][Full Text] [Related]
14. Improving the solubility of vorinostat using cyclodextrin inclusion complexes: The physicochemical characteristics, corneal permeability and ocular pharmacokinetics of the drug after topical application.
Yang J; Ma Y; Luo Q; Liang Z; Lu P; Song F; Zhang Z; Zhou T; Zhang J
Eur J Pharm Sci; 2022 Jan; 168():106078. PubMed ID: 34838620
[TBL] [Abstract][Full Text] [Related]
15. Ternary system of dihydroartemisinin with hydroxypropyl-β-cyclodextrin and lecithin: simultaneous enhancement of drug solubility and stability in aqueous solutions.
Wang D; Li H; Gu J; Guo T; Yang S; Guo Z; Zhang X; Zhu W; Zhang J
J Pharm Biomed Anal; 2013 Sep; 83():141-8. PubMed ID: 23732534
[TBL] [Abstract][Full Text] [Related]
16. Inclusion Complexes of Hydroxy Propyl-β-Cyclodextrin and Paliperidone: Preparation and Characterization.
Sherje A; Londhe V
Curr Drug Discov Technol; 2014; 11(4):271-8. PubMed ID: 25578059
[TBL] [Abstract][Full Text] [Related]
17. Effect of cyclodextrins on the complexation and transdermal delivery of bupranolol through rat skin.
Babu RJ; Pandit JK
Int J Pharm; 2004 Mar; 271(1-2):155-65. PubMed ID: 15129982
[TBL] [Abstract][Full Text] [Related]
18. Characterization of an inclusion complex of cholesterol and hydroxypropyl-beta-cyclodextrin.
Williams RO; Mahaguna V; Sriwongjanya M
Eur J Pharm Biopharm; 1998 Nov; 46(3):355-60. PubMed ID: 9885309
[TBL] [Abstract][Full Text] [Related]
19. Sulfamethoxazole:hydroxypropyl-β-cyclodextrin complex: preparation and characterization.
Garnero C; Aiassa V; Longhi M
J Pharm Biomed Anal; 2012 Apr; 63():74-9. PubMed ID: 22361661
[TBL] [Abstract][Full Text] [Related]
20. Cellulose-based matrix microspheres of prednisolone inclusion complex: preparation and characterization.
Palanisamy M; Khanam J
AAPS PharmSciTech; 2011 Mar; 12(1):388-400. PubMed ID: 21359603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
